ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

NCI Plans Contract To Study Cancer Research Manpower Needs; Epidemiologist State Their Case

October 7, 1977

NCI Moves Slowly, Carcinogenesis CANCERGRAMS For May, June Missing

June 1, 1984

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

AACR considering new office in D.C.

July 18, 2003

Sen. Specter Vows to “Stay and Fight” For Health, Education, On Subcommittee.

February 11, 2005